Natixis Advisors, L.P. Edwards Lifesciences Corp Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 189,889 shares of EW stock, worth $14.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

189,889

Previous 248,405 23.56%

Holding current value

$14.1 Million

Previous $22.9 Million 45.39%

% of portfolio

0.02%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$59.7 - $93.78 $3.49 Million - $5.49 Million	-58,516 Reduced 23.56%	189,889 $12.5 Million
Q2 2024 Aug 01, 2024	BUY	$84.3 - $94.31 $2.2 Million - $2.46 Million	26,038 Added 11.71%	248,405 $22.9 Million
Q1 2024 Apr 25, 2024	SELL	$72.54 - $95.56 $396,793 - $522,713	-5,470 Reduced 2.4%	222,367 $21.2 Million
Q4 2023 Feb 06, 2024	BUY	$61.71 - $77.76 $3.04 Million - $3.83 Million	49,311 Added 27.62%	227,837 $17.4 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $7.65 Million - $10.3 Million	-110,428 Reduced 38.22%	178,526 $12.4 Million
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $1.78 Million - $2.06 Million	21,842 Added 8.18%	288,954 $27.3 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $1.25 Million - $1.43 Million	16,890 Added 6.75%	267,112 $22.1 Million
Q4 2022 Jan 27, 2023	BUY	$68.3 - $87.44 $3.77 Million - $4.83 Million	55,254 Added 28.34%	250,222 $18.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.23 Million - $1.6 Million	14,943 Added 8.3%	194,968 $16.1 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $386,482 - $573,110	4,468 Added 2.55%	180,025 $17.1 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $2.12 Million - $2.67 Million	20,841 Added 13.47%	175,557 $20.7 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $841,812 - $1.03 Million	7,914 Added 5.39%	154,716 $20 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $682,704 - $814,323	-6,634 Reduced 4.32%	146,802 $16.6 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $1.47 Million - $1.83 Million	17,484 Added 12.86%	153,436 $15.9 Million
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $574,442 - $661,981	-7,301 Reduced 5.1%	135,952 $11.4 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $1.25 Million - $1.59 Million	17,462 Added 13.88%	143,253 $13.1 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $465,425 - $605,696	6,927 Added 5.83%	125,791 $10 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $4.78 Million - $6.39 Million	83,094 Added 232.3%	118,864 $8.22 Million
Q1 2020 Apr 27, 2020	SELL	$52.41 - $81.0 $878,286 - $1.36 Million	-16,758 Reduced 31.9%	35,770 $6.75 Million
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $99,591 - $114,023	1,389 Added 2.72%	52,528 $12.3 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $59,457 - $72,865	966 Added 1.93%	51,139 $11.2 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $31,994 - $36,971	-574 Reduced 1.13%	50,173 $9.27 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $224,699 - $300,522	-4,692 Reduced 8.46%	50,747 $9.71 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $88,179 - $108,186	-1,900 Reduced 3.31%	55,439 $8.49 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $1.03 Million - $1.31 Million	-22,552 Reduced 28.23%	57,339 $9.98 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $3.27 Million - $3.95 Million	-76,945 Reduced 49.06%	79,891 $0
Q1 2018 May 10, 2018	BUY	$37.19 - $47.45 $31,351 - $40,000	843 Added 0.54%	156,836 $21.9 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $1.06 Million - $1.24 Million	31,354 Added 25.16%	155,993 $17.6 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $4.52 Million - $4.84 Million	124,639	124,639 $13.6 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Edwards Lifesciences Corp Transaction History